Detalhe da pesquisa
1.
Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.
Biol Blood Marrow Transplant
; 18(9): 1446-54, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22449610
2.
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
Blood
; 112(8): 3500-7, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18664621
3.
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
J Clin Oncol
; 29(7): 805-13, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21220593
4.
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.
Blood
; 111(4): 1848-54, 2008 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18079362
5.
Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen.
Biol Blood Marrow Transplant
; 12(7): 770-7, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16785066
6.
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood
; 105(4): 1408-16, 2005 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15486071
7.
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
Blood
; 100(2): 406-14, 2002 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12091329